1. Home
  2. TXG vs BXSL Comparison

TXG vs BXSL Comparison

Compare TXG & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$42.42

Market Cap

5.0B

Sector

Industrials

ML Signal

HOLD

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$23.54

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
BXSL
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Trusts Except Educational Religious and Charitable
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.5B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
TXG
BXSL
Price
$42.42
$23.54
Analyst Decision
Hold
Buy
Analyst Count
15
10
Target Price
$20.25
$27.18
AVG Volume (30 Days)
3.4M
1.9M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
12.87%
EPS Growth
76.97
N/A
EPS
N/A
0.11
Revenue
$245,893,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.33
N/A
P/E Ratio
N/A
$213.00
Revenue Growth
68.06
N/A
52 Week Low
$11.17
$22.47
52 Week High
$43.23
$32.81

Technical Indicators

Market Signals
Indicator
TXG
BXSL
Relative Strength Index (RSI) 70.45 48.69
Support Level $16.11 $23.26
Resistance Level N/A $24.93
Average True Range (ATR) 2.60 0.46
MACD 0.33 -0.05
Stochastic Oscillator 92.50 32.51

Price Performance

Historical Comparison
TXG
BXSL

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.

Share on Social Networks: